Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asensus has commercialized the Senhance® Surgical System—an FDA-, CE Mark-, Roszdravnadzor-, and PMDA-approved digital laparoscopy robotic platform. Over 10,000 procedures have been performed globally. The next-generation LUNA™ system is under development with integrated augmented intelligence features to further enhance surgeon performance and reduce variability in outcomes. The company’s ISU™ provides real-time intraoperative insights using machine vision and deep learning.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asensus Surgical.